Customers should return these devices to the manufacturer due to a risk of the tip separating during use. 

After being off the U.S. market for nearly four years, the radiotracer thallium-201 is once again available. According to Curium, the decision to bring it back came after communicating with the nuclear cardiology community.

The cardiologist, 63, was arrested on charges of rape, sexual battery and gross sexual imposition. The Brown County Sheriff's Office believes there are additional victims who have not yet come forward.

The patient had a habit of holding sewing needles in his mouth while he worked as a tailor. He did not mention this at first, however, creating a challenge for his care team.

Patients given the drug in question could face an increased risk of blood vessel blockages or inflammation.  

An increase of nearly 200% in the use of CCTA over the past year has driven policy changes.

A Florida resident, 55, nearly died from a pulmonary embolism in 2025. A new lawsuit claims he would have gone to the hospital much sooner if not for a chatbot's guidance. 

A team of specialists detailed new data and recent breakthroughs in the diagnosis, management and treatment of heart failure with preserved ejection fraction.

Today's sophisticated mapping systems allow clinicians to visualize VT circuits with unprecedented detail.

The same device was previously recalled back in 2022. Customers are urged to return any unused delivery systems included in the recall to Medtronic.

Patients were randomized to undergo treatment with the new-look AnchorMan or the Watchman 2.5. A follow-up study comparing the AnchorMan to the Watchman FLX and FLX Pro devices is already planned.

The figure comes from research by Fidelity Investments. The group said their estimate, updated annually, jumped 7.5% since last year.

How is it that pharma companies—and, by extension, health insurers that cover drugs—have targets on their backs while hospitals live like wallflowers?